MGC Pharmaceuticals

MGC Pharma Updates the Market on Operations and Share Purchase Plan

The companyofficially kicked off Phase II CogniCann Clinical Trials last week, while alsoraising over AUD$2 million via a strategic placement and Share Purchase Plan. The European ...

MGC Pharma Provides COVID-19 Update

Despite significant hindrances caused by lockdowns throughout Europe, MGC Pharma has continued its operations and managed to deliver over 1,800 phytocannabinoid medicines througho...

MGC Pharma To Develop Anti-Viral Drug

Share prices in MGC Pharma nearly doubled overnight after the company announced a new agreement in producing an anti-viral drug. MGC Pharmaceuticals (ASX:MXC) a European-based 'See...

MGC Pharma Commences Trial on COVID-19 Patients

MGC Pharma has announced it has commenced the Phase II clinical trial for its trial drug ArtemiC on patients diagnosed with COVID-19. MGC Pharmaceuticals (ASX:MXC), a European base...

ASX Pot Stocks Earnings Review for March Quarter

Here's how Australian cannabis stocks performed in the most recent quarter ending in March 2020. If you thought last quarter was rough for pot stocks...Just a few months ago, we we...

MGC Pharma's COVID-19 Drug Reaches Phase II in Israel

MGC Pharmaceuticals has just received Ethics approval to conduct Phase II trials at a second Israel hospital to study the impacts of its unique formula on patients with COVID-19. M...

Take a Bow – Canopy Growth Wins Awards and Kicks Off Social Outreach Program

Aurora's CBD oil is approved for sale in Ireland, Curaleaf opens its 28th dispensary in Florida, Cresco enters into an equity distribution agreement with Canaccord Genuity Corp, an...

Aussie Invasion – Althea Acquires Peak Solutions and Cronos Holds IPO for Australian Subsidiary

CV Sciences expands its CBD Oil Brand, MGC Pharma hits a new patient milestone, Botanix secures a grant from the Australian Government, and more!There was big news from Althea Grou...

Our Top 3 Cannabis Biotech Stocks For 2020

The Green Fund's CEO, Mark Bernberg, sat down with Stockhead to discuss his top 3 cannabis biotech plays for 2020. This story originally appeared on Stockhead As market watchers wo...